Panacea Life Sciences Holdings, Inc. (PLSH) Operating cash flow 2014–2023
Panacea Life Sciences Holdings, Inc. (PLSH) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$1.5MFY2023 · since FY2014: -$399,650 → -$1.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$1.5M | +36.5% |
| FY2022 | -$2.4M | +38.8% |
| FY2021 | -$3.9M | +48.7% |
| FY2020 | -$7.6M | -33.1% |
| FY2019 | -$5.7M | -1133.8% |
| FY2018 | -$465,755 | +62.3% |
| FY2017 | -$1.2M | -38.6% |
| FY2016 | -$890,956 | -39.2% |
| FY2015 | -$640,020 | -60.1% |
| FY2014 | -$399,650 | — |
Source: SEC XBRL filings · For reference only · Not investment advice